AI Summary & Key Takeaways
AI InsightIn this case report, a 14 years old boy having developed orchiepididymitis one week after mumps infection was presented who was treated with interferon alpha (Roferon, Roche) for 7 days successfully and had no side effects
📌 3 Key Takeaways
Abstract
Although mumps is known to be a self-limiting disease, it can result in testicular atrophy and infertility when it causes orchiepididymitis as a complication in adolescents and young adults. Although not commonly accepted treatment choices, generally used therapies include broad-spectrum antibiotics, analgesic-anti-inflammatory drugs, elevation of testicles and rest. But since these therapies can not prevent the occurrence of testicular atrophy, it is reported that additional interferon therapy may prevent testicular atrophy (1). In this case report, a 14 years old boy having developed orchiepididymitis one week after mumps infection was presented who was treated with interferon alpha (Roferon, Roche) for 7 days successfully and had no side effects
Özet
Kabakulak genellikle kendi kendini sinirlayan bir hastalik olarak bilinmesine karsin özellikle adölesan ve genç eriskinlerde orsiepididimite neden oldugunda testiküler atrofi ve dolayisiyla infertilite ile sonuçlanabilmektedir. Yaygin kabul gören bir tedavi seçecegi olmamakla birlikte genelde kullanilan tedaviler genis etki spektrumlu antibiyotikler, analjezik-antienflamatuvar tedavi, testis elevasyonu ve testislere buz tatbik edilmesidir. Ancak tüm bu tedavilerin testis atrofisini engelleyememesi nedeniyle bu tedavilere ek olarak kullanilacak interferon tedavisinin testis atrofisini engelleyebilecegi belirtilmektedir (1). Bu yazida, 14 yasindaki erkek olguda kabakulak enfeksiyonundan yaklasik 1 hafta sonra gelisen orsiepididimit olgusunda testis atrofisi ve infertilite riskini en aza indirmek amaciyla 7 günlük interferon alfa (Roferon, Roche) tedavisi ile basarili bir sekilde tedavi edilen ve herhangi bir yan etki gelistirmeyen bir olgu sunuldu